These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38416563)

  • 1. The Effectiveness of National Expanded Program on Immunization With Hepatitis A Vaccines in the Chinese Mainland: Interrupted Time-Series Analysis.
    Ming BW; Li L; Huang HN; Ma JJ; Shi C; Xu XH; Yang Z; Ou CQ
    JMIR Public Health Surveill; 2024 Feb; 10():e53982. PubMed ID: 38416563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004-2016.
    Sun X; Wang F; Zheng H; Miao N; Yuan Q; Cui F; Yin Z; Zhang G; Levine H
    Vaccine; 2018 Feb; 36(10):1279-1284. PubMed ID: 29398275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in seroprevalence of hepatitis A after the implementation of universal childhood vaccination in Shandong Province, China: A comparison between 2006 and 2014.
    Yan BY; Lv JJ; Liu JY; Feng Y; Wu WL; Xu AQ; Zhang L
    Int J Infect Dis; 2019 May; 82():129-134. PubMed ID: 30862519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the expanded program on immunization on the incidence of Japanese encephalitis in different regions of Mainland China: An interrupt time series analysis.
    Shi T; Meng L; Li D; Jin N; Zhao X; Zhang X; Liu Y; Zheng H; Zhao X; Li J; Shen X; Ren X
    Acta Trop; 2022 Sep; 233():106575. PubMed ID: 35768039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of hepatitis B immunization in the Expanded Program on Immunization of the Child Survival Project.
    Mansour E; Abdul-Rahim S; Batouty G; Zaghloul I; Abdel-Hadi S
    J Egypt Public Health Assoc; 1993; 68(5-6):487-94. PubMed ID: 7775876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of universal live attenuated hepatitis A vaccines in Henan, China, 2005-2018.
    Guo Y; Zhang L; Feng D; Zhao S; Liu Q; Xu J; Lu M; Li J; Zhang Y; Guo W
    Int J Infect Dis; 2020 Apr; 93():163-167. PubMed ID: 32045695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiological analysis of viral hepatitis A in China, 2004-2015].
    Sun XJ; Wang FZ; Zheng H; Miao N; Yuan QL; Wang HQ; Yin ZD; Zhang GM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Dec; 51(12):1091-1096. PubMed ID: 29262490
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence of hepatitis A in Israel following universal immunization of toddlers.
    Dagan R; Leventhal A; Anis E; Slater P; Ashur Y; Shouval D
    JAMA; 2005 Jul; 294(2):202-10. PubMed ID: 16014594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The shifting epidemiology of hepatitis A following routine childhood immunization program in Israel.
    Chodick G; Green MS; Heymann AD; Rosenmann L; Shalev V
    Prev Med; 2007 Nov; 45(5):386-91. PubMed ID: 17599401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trend in the incidence of hepatitis A in mainland China from 2004 to 2017: a joinpoint regression analysis.
    Li YS; Zhang BB; Zhang X; Fan S; Fei LP; Yang C; Ren NJ; Li X; Luo YM; Zhang JH
    BMC Infect Dis; 2022 Aug; 22(1):663. PubMed ID: 35915398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of 10-year vaccination (2001-2010) on Hepatitis A in Tianjin, China.
    Zhang ZL; Zhu XJ; Shan AL; Gao ZG; Zhang Y; Ding YX; Liu H; Wu WS; Liu Y; He HY; Xie XH; Xia WD; Li C; Xu WT; Li ZY; Lin HL; Fu WM
    Hum Vaccin Immunother; 2014; 10(4):1008-12. PubMed ID: 24503599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation and analysis of antibody levels of hepatitis A among children before and after implementing the Expanded National Immunization Program in China.
    Xu WB; Li Y; Li D; Fang Y; An ZJ; Teng X; Wang HQ; Shang QL
    Vaccine; 2020 Jan; 38(4):878-881. PubMed ID: 31733948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The coverage of hepatitis A vaccine among 2-29 year olds and the reporting incidence of hepatitis A in China, 2014].
    Wang FZ; Zheng H; Liu JH; Sun XJ; Miao N; Shen LP; Zhang GM; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1099-104. PubMed ID: 27539340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the national hepatitis B immunization program in China: a modeling study.
    Liu Z; Li M; Hutton DW; Wagner AL; Yao Y; Zhu W; Cao L; Tang S; Pan J; Wang Y; Zhao Q; Ren H; Wang Y; Wang W
    Infect Dis Poverty; 2022 Oct; 11(1):106. PubMed ID: 36221140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing Epidemiology of Hepatitis A in China: Evidence From Three National Serological Surveys and the National Notifiable Disease Reporting System.
    Wang F; Sun X; Wang F; Zheng H; Jia Z; Zhang G; Bi S; Miao N; Zhang S; Cui F; Li L; Wang H; Liang X; Rodewald LE; Feng Z; Yin Z; Shen L
    Hepatology; 2021 Apr; 73(4):1251-1260. PubMed ID: 32592242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multi-Age-Group Interrupted Time-Series Study for Evaluating the Effectiveness of National Expanded Program on Immunization on Mumps.
    Shi C; Liu WH; Yang L; Yan ZL; Li L; Zhang ZB; Ou CQ
    Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in Adults.
    Wang Z; Chen Y; Xie S; Lv H
    PLoS One; 2016; 11(4):e0153804. PubMed ID: 27093614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of hepatitis A antibody among population covered by different hepatitis A immunization strategies in Shandong Province, 2015, China].
    Kong Q; Yan BY; Lyu JJ; Feng Y; Liu JY; Song LZ; Xu Q; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):480-483. PubMed ID: 28592089
    [No Abstract]   [Full Text] [Related]  

  • 19. An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China.
    Yin Z; Beeler Asay GR; Zhang L; Li Y; Zuo S; Hutin YJ; Ning G; Sandhu HS; Cairns L; Luo H;
    Vaccine; 2012 Aug; 30(37):5569-77. PubMed ID: 22698453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
    Kane MA; Hadler SC; Lee L; Shapiro CN; Cui F; Wang X; Kumar R
    Vaccine; 2013 Dec; 31 Suppl 9():J15-20. PubMed ID: 24331015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.